Related references
Note: Only part of the references are listed.METTL3 regulates breast cancer-associated alternative splicing switches
Cyrinne Achour et al.
ONCOGENE (2023)
Critical Roles of METTL3 in Translation Regulation of Cancer
Wangyang Meng et al.
BIOMOLECULES (2023)
Remodeling of the m6A RNA landscape in the conversion of acute lymphoblastic leukemia cells to macrophages
Alberto Bueno-Costa et al.
LEUKEMIA (2022)
Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia
Eliza Yankova et al.
NATURE (2021)
Splicing factor mutations in hematologic malignancies
Sisi Chen et al.
BLOOD (2021)
Epitranscriptomics in Hematopoiesis and Hematologic Malignancies
Margalida Rossello-Tortella et al.
BLOOD CANCER DISCOVERY (2020)
Epigenetic inactivation of the splicing RNA-binding protein CELF2 in human breast cancer
Laia Pique et al.
ONCOGENE (2019)
Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependencies
Elisa ten Hacken et al.
JCI INSIGHT (2018)
FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase
Zejuan Li et al.
CANCER CELL (2017)